The automated and closed cell therapy market is estimated to grow at a CAGR of 22.05% during the forecast period.
In closed-system cell therapy, automation is commonly incorporated to streamline and standardize production procedures. Automated systems are capable of carrying out various tasks such as expanding cells, harvesting and separating them, and preparing formulations. Multiple associated benefits with automation in cell therapy along with the growing popularity of regenerative medicines are major growth drivers of the automated and closed cell therapy market. Moreover, the growing prevalence of cancer cases coupled with technological advancements and investments in the field are further expected to boost the automated and closed cell therapy market.
Multiple Associated Benefits
There are various benefits associated with automation which is aiding the automation and closed cell therapy market. Automation in cell therapy provides process standardization, assuring uniform and repeatable cell therapies. Closed systems make it possible to produce more cells in a given time while preserving quality and lowering the chance of an error, which helps with scalability. Closed systems offer a controlled setting for cell therapies, reducing the danger of contamination and guaranteeing the security of cellular products. Automated and closed-cell treatments can increase productivity while lowering labor expenses. Cell treatments are increasingly appealing and available to consumers and healthcare professionals due to their cost-effectiveness.
Increasing Popularity of Regenerative Medicines
Regenerative medicine has grown in popularity recently because it has the potential to transform healthcare by utilizing the body's innate ability to heal itself to repair. The growing popularity of regenerative medicine is a major growth driver of the automated and closed-cell therapy market. Various government measures are supporting the adoption of regenerative medicine. For instance, the NIST Regenerative Medicine program is working closely with FDA to develop global manufacturing and measurement standards. Moreover, NIST Laboratory programs support the regenerative medicine industry by developing new methods for quantitative measurements, providing reference materials, and establishing partnerships to develop measurement solutions.
Growing Prevalence of Cancer
Automated cell therapyhas demonstrated remarkable prospects for the treatment of cancer. For example, personalized immunotherapy known as chimeric antigen receptor T-cell (CAR-T) treatment involves altering a patient's T cells so that they can detect and combat cancer cells. The rising cancer cases are therefore expected to bolster the automated and closed cell therapy market. For instance, cancer is the leading death cause with more than 10 million worldwide deaths in 2020 according to the WHO. There were around 18 million new cancer cases worldwide in 2020 as per the WCRF with breast cancer being the most common type accounting for almost 12.5% of overall cases.
Increasing Investments in the Field
The increasing investments in cell therapies to automate the procedure are expected to propel the automated and closed cell therapy market. For instance, Ori Biotech received an investment of €88 million in series B cash to ease the cell therapy manufacturing bottleneck using automation and standardized data collection. Additionally, Cellaries raised $82 million to develop the Cell Shuttle platform which is a modular end-to-end cell therapy factory that leverages automation and quickly turns out a finished product ready for infusion. The platform will require about 80% less cleanroom space than manual production.
Restraints in the Market
A few factors are there which are expected to limit the automated and closed cell therapy market. The essential resources, including clean room facilities, qualified staff, and capacity for process development, may not be present at many healthcare institutions and research organizations. Automated system adoption may be hampered by a lack of infrastructure and competent labor. In the automated cell treatment sector, maintaining product quality and standardizing production procedures are continuing problems that may hinder market growth. The extent of human monitoring and engagement in the manufacturing process is another issue raised by the use of automation in cell therapy that may influence the general public's view and acceptability.
North America is Expected to Grow Significantly
The North American region is anticipated to hold a significant share of the automated and closed cell therapy market. Various factors attributed to such a share are technological advancements, digitalization in healthcare, higher cancer cases, and awareness among healthcare providers and patients. For instance, CDRH established the Digital Health Center of Excellence which seeks to empower digital health stakeholders to advance health care in 2020. Moreover, the new cancer cases in the US were around 1.9 million in 2022 as per the American Cancer Society. Additionally, the presence of major market players such as Miltenyi Biotec, and Cytiva further propels the automated and closed cell therapy market in the region.
Major Market Players
Lonzais a multinational business that offers sophisticated production and research services to the biopharmaceutical, speciality ingredient, and healthcare industries. Cocoon® platform designed by the company offers cell therapy manufacturing with automated and closed integration.
Miltenyi Biotecis a global biotechnology company that specializes in providing tools, instruments, and solutions for cellular therapy, cell biology, and immunology research. Their MACS (Magnetic-Activated Cell Sorting) technology is widely used in research laboratories and clinical settings for cell isolation and enrichment.
Fresenius Kabiis a global healthcare company that focuses on infusion treatment, clinical nutrition, anesthesia, and critical care. Cue® cell processing platform developed by the company offers an automated small cell processing system that addresses critical unmet medical needs.
Key Market Developments
In May 2023,Cellular Origins launched its configurable robotic platform Constellation™ to enable scalable manufacturing of advanced cell therapies. It combines aseptic fluid handling technologies with advanced automation from the Industry 4.0 revolution.
In October 2022,to hasten the development of cell therapies in the Asia Pacific region, Thermo Fisher Scientific established a Cell Therapy Collaboration Centre Programme in Singapore. The program seeks to give cell therapy pioneers the tools they need to move quickly from process development to technology transfer for curative cell treatments.
In October 2022,for simple commercial manufacture of cell treatments, Thermo Fisher Scientific introduced the GibcoTM CTSTM DynaCellectTM Magnetic Separation System. With the help of this technology, production defects are kept to a minimum and the appropriate cells are segregated.
Segmentation:
By Workflow
Separation
Expansion
Apheresis
Fill-Finish
Cryopreservation
Others
By Type
Stem Cell Therapy
Non-Stem Cell Therapy
By Scale
Pre-commercial/R&D Scale
Commercial Scale
By Geography
North America
United States
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
United Kingdom
Germany
France
Spain
Others
Middle East and Africa
Saudi Arabia
UAE
Israel
Others
Asia Pacific
Japan
China
India
South Korea
Indonesia
Thailand
Others
Table of Contents
1. INTRODUCTION
1.1. Market Overview 1.2. Market Definition 1.3. Scope of the Study 1.4. Market Segmentation 1.5. Currency 1.6. Assumptions 1.7. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Data 2.2. Assumptions
3. EXECUTIVE SUMMARY
3.1. Research Highlights
4. MARKET DYNAMICS
4.1. Market Drivers 4.2. Market Restraints 4.3. Porter’s Five Force Analysis 4.3.1. Bargaining Power of Suppliers 4.3.2. Bargaining Power of Buyers 4.3.3. Threat of New Entrants 4.3.4. Threat of Substitutes 4.3.5. Competitive Rivalry in the Industry 4.4. Industry Value Chain Analysis
5. AUTOMATED AND CLOSED CELL THERAPY MARKET, BY WORKFLOW
8. AUTOMATED AND CLOSED CELL THERAPY MARKET, BY GEOGRAPHY
8.1. Introduction 8.2. North America 8.2.1. United States 8.2.2. Canada 8.2.3. Mexico 8.3. South America 8.3.1. Brazil 8.3.2. Argentina 8.3.3. Others 8.4. Europe 8.4.1. United Kingdom 8.4.2. Germany 8.4.3. France 8.4.4. Spain 8.4.5. Others 8.5. The Middle East and Africa 8.5.1. Saudi Arabia 8.5.2. UAE 8.5.3. Israel 8.5.4. Others 8.6. Asia Pacific 8.6.1. Japan 8.6.2. China 8.6.3. India 8.6.4. South Korea 8.6.5. Indonesia 8.6.6. Thailand 8.6.7. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis 9.2. Emerging Players and Market Lucrativeness 9.3. Mergers, Acquisitions, Agreements, and Collaborations 9.4. Vendor Competitiveness Matrix
10. COMPANY PROFILES
10.1. MiltenyiBiotec 10.2. Lonza 10.3. Fresenius Kabi 10.4. Cytiva (Danaher Corp.) 10.5. BioSpherix, Ltd. 10.6. Terumo Corporation 10.7. Sartorius AG 10.8. ThermoGenesis Holdings, Inc. 10.9. Cellares Inc. 10.10. Thermo Fisher Scientific, Inc.
This product is a market research report. Each license type allows a set number of users to access the report. Please select an option from the list below. This product is a market research report. This is a single user license, allowing one user access to the product. The product is a PDF. This product is a market research report. This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF. This product is a market research report. This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF.
The sample excerpt is provided to help you make an informed purchasing decision. It is not intended to serve as free content or replace a full report. To ensure the sample aligns with your specific needs, our team will contact you to better understand your requirements.
An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net
This report can be tailored to focus on a specific country, region, continent, or provide global coverage. Please indicate your regions of interest and share any additional questions you may have. Our team strives to respond to all inquiries within the same business day.
An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net
*Required Information
This website uses cookies to ensure you get the best experience. Learn more